Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti–SARS-CoV-2 antibodies in the absence of CXCL13

Since the initial spread of severe acute respiratory syndrome coronavirus 2 infection, several viral variants have emerged and represent a major challenge for immune control, particularly in the context of vaccination. We evaluated the quantity, quality, and persistence of immunoglobulin G (IgG) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Azarias Da Silva, Marne, Nioche, Pierre, Soudaramourty, Calaiselvy, Bull-Maurer, Anne, Tiouajni, Mounira, Kong, Dechuan, Zghidi-Abouzid, Ouafa, Picard, Morgane, Mendes-Frias, Ana, Santa-Cruz, André, Carvalho, Alexandre, Capela, Carlos, Pedrosa, Jorge, Castro, António Gil, Loubet, Paul, Sotto, Albert, Muller, Laurent, Lefrant, Jean-Yves, Roger, Claire, Claret, Pierre-Géraud, Duvnjak, Sandra, Tran, Tu-Anh, Tokunaga, Kenzo, Silvestre, Ricardo, Corbeau, Pierre, Mammano, Fabrizio, Estaquier, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403221/
https://www.ncbi.nlm.nih.gov/pubmed/37540749
http://dx.doi.org/10.1126/sciadv.adg2122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403221/
https://www.ncbi.nlm.nih.gov/pubmed/37540749
http://dx.doi.org/10.1126/sciadv.adg2122

Ejemplares similares